Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia

Clinical trial NCT02491398 · COMPLETED

Trial details

NCT number: NCT02491398
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2016-02-01
Primary completion: 2017-01-01
Enrollment: 494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.